A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease
- PMID: 10679792
- DOI: 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0
A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease
Abstract
To facilitate studies of the normal biology of alpha-synuclein, a member of a family of neuronal proteins of unknown function, and to elucidate the role of alpha-synuclein pathologies in neurodegenerative diseases, we generated and characterized a panel of anti-synuclein antibodies. Here we demonstrate that these antibodies recognize defined epitopes spanning the entire length of human alpha-synuclein, and that some of these antibodies also cross-react with zebra finch and rodent synucleins. Since alpha-synuclein has been reported to be a major component of Lewy bodies (LBs) in Parkinson's disease (PD), dementia with LBs and common variants of Alzheimer's disease, we performed immunohistochemical studies showing that these antibodies label numerous LBs in the PD substantia nigra, thereby localizing protein domains throughout human alpha-synuclein in LBs. Taken together, our data indicate that this panel of antibodies can be exploited to probe the normal biology of alpha-synuclein as well as the role of pathological forms of this protein in PD and related neurodegenerative synucleinopathies.
Copyright 2000 Wiley-Liss, Inc.
Similar articles
-
Alpha-synuclein in familial Alzheimer disease: epitope mapping parallels dementia with Lewy bodies and Parkinson disease.Arch Neurol. 2001 Nov;58(11):1817-20. doi: 10.1001/archneur.58.11.1817. Arch Neurol. 2001. PMID: 11708989
-
Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.J Neurol. 2003 Oct;250 Suppl 3:III11-4. doi: 10.1007/s00415-003-1303-x. J Neurol. 2003. PMID: 14579119
-
Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.Am J Pathol. 1998 Apr;152(4):879-84. Am J Pathol. 1998. PMID: 9546347 Free PMC article.
-
[The mechanism of Lewy body formation in Parkinson's disease].Nihon Rinsho. 2000 Oct;58(10):2022-7. Nihon Rinsho. 2000. PMID: 11068441 Review. Japanese.
-
Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia.Arch Neurol. 1998 Feb;55(2):151-2. doi: 10.1001/archneur.55.2.151. Arch Neurol. 1998. PMID: 9482355 Review. No abstract available.
Cited by
-
Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases.NPJ Parkinsons Dis. 2023 Dec 7;9(1):161. doi: 10.1038/s41531-023-00604-y. NPJ Parkinsons Dis. 2023. PMID: 38062007 Free PMC article.
-
Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice.Mol Neurodegener. 2015 Jul 30;10:32. doi: 10.1186/s13024-015-0029-4. Mol Neurodegener. 2015. PMID: 26223783 Free PMC article.
-
Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies.Am J Pathol. 2006 Oct;169(4):1343-52. doi: 10.2353/ajpath.2006.060438. Am J Pathol. 2006. PMID: 17003490 Free PMC article.
-
Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stool.NPJ Parkinsons Dis. 2023 Feb 2;9(1):14. doi: 10.1038/s41531-023-00458-4. NPJ Parkinsons Dis. 2023. PMID: 36732520 Free PMC article.
-
α-Synuclein and Polyunsaturated Fatty Acids: Molecular Basis of the Interaction and Implication in Neurodegeneration.Molecules. 2018 Jun 25;23(7):1531. doi: 10.3390/molecules23071531. Molecules. 2018. PMID: 29941855 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
